- Home
- CRON vs LXRX Comparison
CRON vs LXRX Comparison
Compare CRON & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRON | LXRX |
|---|---|---|
| Founded | N/A | 1995 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 996.7M |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CRON | LXRX |
|---|---|---|
| Price | $3.20 | $2.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.15 |
| AVG Volume (30 Days) | 1.2M | ★ 2.4M |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $146,587,000.00 | $49,803,000.00 |
| Revenue This Year | $26.34 | N/A |
| Revenue Next Year | $15.53 | N/A |
| P/E Ratio | $26.17 | ★ N/A |
| Revenue Growth | 24.63 | ★ 60.24 |
| 52 Week Low | $2.28 | $1.06 |
| 52 Week High | $3.61 | $2.68 |
Technical Indicators
Market Signals| Indicator | CRON | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.31 | 30.49 |
| Support Level | $2.58 | $1.50 |
| Resistance Level | $3.28 | $2.49 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 28.01 | 3.49 |
Price Performance
Historical ComparisonAbout CRON Cronos Group Inc.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.